High Risk: The Debate Over the Price of Specialty Drugs and Zika Virus
In an interview with CFIF, Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
Throughout my legal career, I've always favored what is known as the "English Rule," meaning that losing litigants should generally be required to pay the winning parties' fees and costs.
Under our current "American Rule," in contrast, each side generally pays its own fees and costs, win or lose. That has always struck me as inequitable, because a party forced to spend its valuable time, money and other resources should be left in no worse position for having to vindicate what proved to be the superior legal position. If you're minding your own business and…
"The first Clinton-Trump debate was roughly a draw -- which is bad news for her, because she needs to turn this race around, and she failed. ...Donald Trump remains the candidate of change; Hillary Clinton, the tribune of the status quo."…[more]